Screening of the NIH Clinical Collection for inhibitors of HIV-1 integrase activity

by Shaakira Abrahams, Salerwe Mosebi, Muhammed Q. Fish, Maria A. Papathanasopoulos, Raymond Hewer
Published 2018-03-01

High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen.

by Kim Steegen, Leon Levin, Irene Ketseoglou, Michelle Bronze, Maria A Papathanasopoulos, Sergio Carmona, Wendy Stevens
Published 2014-01-01

High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa.

by Lindiwe Skhosana, Kim Steegen, Michelle Bronze, Azwidowi Lukhwareni, Esrom Letsoalo, Maria A Papathanasopoulos, Sergio C Carmona, Wendy S Stevens
Published 2015-01-01

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.

by Kim Steegen, Sergio Carmona, Michelle Bronze, Maria A Papathanasopoulos, Gert van Zyl, Dominique Goedhals, William MacLeod, Ian Sanne, Wendy S Stevens
Published 2016-01-01

HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.

by Michelle Bronze, Kim Steegen, Carole L Wallis, Hans De Wolf, Maria A Papathanasopoulos, Margriet Van Houtte, Wendy S Stevens, Tobias Rinke de Wit, Lieven J Stuyver, ART-A Consortium
Published 2012-01-01

Molecular characterisation of rifampicin-resistant <i>Mycobacterium tuberculosis</i> strains from Malawi

by Tarsizio Chikaonda, Irene Ketseoglou, Nelson Nguluwe, Robert Krysiak, Isaac Thengolose, Felix Nyakwawa, Nora E. Rosenberg, Christopher Stanley, James Mpunga, Irving F. Hoffman, Maria A. Papathanasopoulos, Mina Hosseinipour, Lesley Scott, Wendy Stevens
Published 2017-03-01